SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

PHYLOGICA LIMITED (PYC)

Former Name ASX

Former (or subsequent) names

 FROMTO
PYC THERAPEUTICS LIMITED28/11/2019
PHYLOGICA LIMITED28/11/2019

Shareholder links

Our website ranking of PYC: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Security Transfer Australia Pty Ltd, 770 Canning Highway Applecross WA 6153

Tel : +61 3 9628 2200
Fax : +61 8 9315 2233
RegistryWebsite RegistryEmail

Company details

Address: Suite 8, 7 The Esplanade Mt Pleasant WA 6153
Tel:  +61 8 9316 9100 Fax: +61 8 9315 5475

Date first listed: 30/03/2005
Company Secretary: Kevin Hart
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Developing peptide-based therapeutics

name changed to PYC Therapeutics Limited

28/11/2019

The suspension of trading in the securities of Phylogica Limited will be lifted from the commencement of trading today, Wednesday, 12 September 2018, following the release by PYC of an announcement regarding a capital raising.

12/09/2018

The company has received firm commitments to raise $9.12 m (before costs) through a placement of shares to both new and existing sophisticated and institutional investors at a price of 3 cents per new security. The placement will occur in two tranches.

12/09/2018

The company's capital raising is conducted at a price of 3 cents per share. It is an excluded offer available to professional investors only and will introduce new sophisticated and institutional investors to Phylogica's register. This is being supported by the company's existing major shareholders and will provide funding for 3 primary activities.

11/09/2018

The securities of Phylogica Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of PYC, pending the release of an announcement regarding a capital raising.

11/09/2018

shares reinstated to quotation

18/08/2010

company advises that the signing of formal documentation with a large pharmaceutical and biotechnology group regarding a new research partnership utilizing the Company's proprietary library of protein fragments (Phylomer peptides) is now imminent

16/08/2010

company says it believes it will have enough cash to finance activities over the next two quarters

09/08/2010

shares suspended from quotation pending release of an announcement

05/08/2010

the suspension of trading in the securities of Phylogica Limited (the "Company") will be lifted immediately following receipt of an announcement by the Company

08/12/2009

shares suspended from quotation pending release of an announcement

03/12/2009

shares reinstated to quotation

31/08/2006

shares suspended from quotation pending release of an announcement

29/08/2006

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    12/04/2019Alan Tribe300,000$0.025$7,500
    14/10/2016Bernard Hockings3,000,000$0.006$17,000
    10/10/2016Bernard Hockings3,000,000$0.015$46,219
    10/08/2015Bernard Hockings-18,631,578$0.010$186,315
    30/07/2015Bernard Hockings-2,679,822$0.001$2,680

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Alan TribeNon Exec Chairman11/04/2018
    Kevin HartCFO24/07/2017
    Bernard HockingsNon Exec Director24/01/2014
    Rohan HockingsDirector, CEO15/08/2016

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Sahm NasseriNon Exec Director23/10/201711/02/2019
    Robert HayesExecutive Director18/04/201730/11/2018
    Stephanie UnwinNon Exec Director, CEO18/01/201627/04/2018
    Michael WilliamsNon Exec Director03/01/201811/04/2018
    Paul WattNon Exec Director09/08/200224/11/2017
    Rick KendallIndependent Director18/04/201723/10/2017
    Graeme BodenCFO19/07/201324/07/2017
    Jeremy CookNon Exec Director01/03/201218/04/2017
    Douglas WilsonNon Exec Director10/12/200725/11/2016
    Richard HopkinsCEO19/07/201301/10/2016
    Bruce McHarrieNon Exec Chairman09/08/200209/04/2016
    Nick WoolfCFO22/04/201019/07/2013

    Date of first appointment, title may have changed.